| Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. | breast, |
| Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status. | liver,breast, |
| DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. | bladder, |
| HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats. | endometrial, |
| [DNA content and c-erbB-2 oncoprotein expression in hepatic metastases from colorectal carcinoma--in relation to clinicopathologic findings and prognosis]. | colorectal,liver, |
| An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance. | breast, |
| Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma. | breast, |
| HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer. | breast, |
| In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit. | breast, |
| Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma. | breast, |
| HER-2/neu oncogene expression and proliferation in breast cancers. | breast, |
| Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. | breast, |
| Studies of the HER-2/neu proto-oncogene in human breast cancer. | breast, |
| Co-expression of N-ras p21 and C-erbB-2 (neu) oncogene products by common ALL antigen-positive aggressive diffuse lymphoma. | lymphoma, |
| Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases. | breast, |
| Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues. | breast, |
| Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. | bladder, |
| HER-2/neu oncogene amplification and expression in breast and ovarian cancers. | breast,ovarian, |
| Neu (C-erbB-2) oncogene in breast cancer and its possible association with the risk of distant metastases. A retrospective study and review of literature. | breast, |
| Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi s sarcoma. | sarcoma, |